Cellular Immune Response to BNT162b2 mRNA COVID-19 Vaccine in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital
We describe the results of a T-cell immunity evaluation performed after a median elapsed time of 7 months from second-dose BNT162b2 vaccine administration, in a representative sample of 419 subjects from a large cohort of hospital workers. Overall, the Quantiferon SARS-CoV-2 assay detected a respons...
Main Authors: | Cristina Costa, Gitana Scozzari, Enrica Migliore, Claudia Galassi, Giovannino Ciccone, Guido Ricciardelli, Antonio Scarmozzino, Lorenzo Angelone, Paola Cassoni, Rossana Cavallo, on behalf of the Collaborative Group |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-06-01
|
Series: | Vaccines |
Subjects: | |
Online Access: | https://www.mdpi.com/2076-393X/10/7/1031 |
Similar Items
-
Factors Influencing Level and Persistence of Anti SARS-CoV-2 IgG after BNT162b2 Vaccine: Evidence from a Large Cohort of Healthcare Workers
by: Cristina Costa, et al.
Published: (2022-03-01) -
Prevalence, Persistence, and Factors Associated with SARS-CoV-2 IgG Seropositivity in a Large Cohort of Healthcare Workers in a Tertiary Care University Hospital in Northern Italy
by: Gitana Scozzari, et al.
Published: (2021-06-01) -
Immunogenicity of mRNA-1273 and BNT162b2 in Immunocompromised Patients: Systematic Review and Meta-analysis Using GRADE
by: Sushma Kavikondala, et al.
Published: (2024-05-01) -
Hemophagocytic Lymphohistiocytosis Following BNT162b2 mRNA COVID-19 Vaccination
by: Ting-Yu Lin, et al.
Published: (2022-04-01) -
Overview of Anti-SARS-CoV-2 Immune Response Six Months after BNT162b2 mRNA Vaccine
by: Claudia Gandolfo, et al.
Published: (2022-01-01)